RecoverRx is the Hot Topic Today Electroceutica
Post# of 8465
(Total Views: 444)
Posted On: 07/07/2022 10:31:17 AM
RecoverRx is the Hot Topic Today
Electroceuticals: Technologies and Global Markets
Jul 2022| MDS001B| BCC Publishing
Report Includes:
* 19 data tables and 24 additional tables
* An overview of global markets and technologies for electroceuticals
* Analyses of global market trends, with data from 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
* Discussion on how electroceuticals are used as an alternative to drug-based remedies and analyses of endogenous and exogenous factors that are impacting the global market growth
* Coverage of several diseases such as epilepsy, cardiovascular diseases, rheumatoid arthritis and diabetes and their treatment using electroceuticals
* Information on RecoveryRx medical device, which is used for the treatment of postoperative pain of opioid/NSAID therapy
* Coverage of regulatory landscape, product recalls, pipeline products, and discussion on future perspective, strategies, and developments of the industry
Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size, and forecast
* Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
* Company profiles of major players Abbott Laboratories, Boston Scientific, GlaxoSmithKline plc, Medtronic plc, Edwards Lifesciences Corp.
https://www.bccresearch.com/market-research/m...eport.html
The only electroceutical product specifically mentioned in this report teaser is RecoveryRx. Why would BCC research do this? Because BIEL's RecoveryRx campaign is creating interest and a Buzz about the product. BCC feels their possible customers want more information on RecoveryRx.
Electroceuticals: Technologies and Global Markets
Jul 2022| MDS001B| BCC Publishing
Report Includes:
* 19 data tables and 24 additional tables
* An overview of global markets and technologies for electroceuticals
* Analyses of global market trends, with data from 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
* Discussion on how electroceuticals are used as an alternative to drug-based remedies and analyses of endogenous and exogenous factors that are impacting the global market growth
* Coverage of several diseases such as epilepsy, cardiovascular diseases, rheumatoid arthritis and diabetes and their treatment using electroceuticals
* Information on RecoveryRx medical device, which is used for the treatment of postoperative pain of opioid/NSAID therapy
* Coverage of regulatory landscape, product recalls, pipeline products, and discussion on future perspective, strategies, and developments of the industry
Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size, and forecast
* Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
* Company profiles of major players Abbott Laboratories, Boston Scientific, GlaxoSmithKline plc, Medtronic plc, Edwards Lifesciences Corp.
https://www.bccresearch.com/market-research/m...eport.html
The only electroceutical product specifically mentioned in this report teaser is RecoveryRx. Why would BCC research do this? Because BIEL's RecoveryRx campaign is creating interest and a Buzz about the product. BCC feels their possible customers want more information on RecoveryRx.
(4)
(0)